Trending Now
Loop Media Inc (NYSE American: LPTV) could be a small cap...
We'd like to spotlight Loop Media, Inc. (NYSE American: LPTV), a stock currently priced at $2.90 and deserving of your immediate focus....
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Precigen Inc. (NASDAQ: PGEN) Presents Positive Preliminary PRGN-3006 UltraCAR-T Data in...
Precigen Inc. (NASDAQ: PGEN) has presented positive preliminary data from the ongoing phase 1/1b clinical study of PRGN-3006 UltraCAR-T in refractory or relapsed acute...
MAKE IT MODERN
LATEST REVIEWS
Abeona Therapeutics Inc (NASDAQ: ABEO) Reports Positive Data Of Its Ongoing...
Abeona Therapeutics Inc (NASDAQ:ABEO) reported new interim positive data from its Phase 1/2 ongoing clinical studies of ABO-101 and ABO-102 in MPS IIIB and...
MAKE IT MODERN
PERFORMANCE TRAINING
Electric Vehicle Stocks For the Win (WKHS, KULR, BYDDY, FCEL)
The rush to drive a new paradigm in the automobile space is already well underway, with the Biden administration announcing this week...
Small Cap MMA Stock B2Digital (BTDG) Deep Dive: Apple iPhone Event Set for this...
How undervalued are shares of B2Digital Inc (OTC US:BTDG) right now?
The stock is trading at a market cap...
This is where Invesco QQQ Trust Series 1 (QQQ) is headed next
After an attempt higher, the QQQ’s are getting hit again this morning now trading in negative territory as the market leader NVDA...
Invesco QQQ Trust Series 1 (QQQ) surges giving bulls a psychological boost
The market was in risk off mode yesterday, but the buyers have stepped back in this morning in the QQQ’s. I don’t...
Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) Announces CRV431 Study Results In Liver Disease
Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) has announced results from its translational research study of CRV431, it's lead drug candidate. CRV431 demonstrated a decrease...
MAKE IT MODERN
